Skip to main content
. 2009 Mar 2;27(10):1675–1684. doi: 10.1200/JCO.2008.18.2717

Fig A2.

Fig A2.

(A) Serum thyroglobulin (Tg) levels with therapy in patients with papillary thyroid cancer (PTC) on arm A (n = 9). (B) Serum thyroglobulin levels with therapy in patients with PTC on arm B (n = 9). Patients 023, 048, 013, 029, 044 were cytotoxic chemotherapy-naïve PTC patients while 006, 021, 052, 034 had prior cytotoxic chemotherapy. 005-PR, patient No. 005 who has partial response (PR) by Response Evaluation Criteria in Solid Tumors (RECIST); 006-PR, patient No. 006 in arm B who has partial response (PR) by RECIST; SD, stable disease; PD, progressive disease.